Debra J. Wilson - Concepedia

Concepedia

Author

Debra J. Wilson

National Institutes of Health

Also Known As

D J Wilson, D. J. Wilson, DEBRA J. WILSON, Debra J. Wilson, Wilson, D

15

Publications

1.1K

Citations

11

H-Index

37

Concepts

All Affiliations

National Institutes of Health Melanoma Institute Australia National Institute of Neurological Disorders and Stroke National Cancer Institute Thoracic Surgery Foundation

DJ

About

Debra J. Wilson is an author at National Institutes of Health specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	865
2	Cell Biology	5	5	555
3	Engineering	1	1	118
4	Allergy	1	1	354
5	Cellular Therapies	1	1	77

Debra J. Wilson

×

11

Publications

1.1K

Citations

11

H-Index

	Year	Citations
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. Elizabeth A. Grimm, R J Robb, Jack A. Roth, The Journal of Experimental Medicine ImmunologyImmunologic MechanismImmune SystemImmunotherapyNatural Killer Cells	1983	354
Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial. Steven K. Jacobs, Debra J. Wilson, Paul L. Kornblith, PubMed Brain Tumor PatientsLak CellsImmunologyCell DeathHigh-grade Gliomas	1986	138
NIH guidelines for research involving recombinant DNA molecules Debra J. Wilson Accountability in Research National InstitutesDna SequencingDna NanotechnologyEngineeringHealth Guidelines	1993	118
Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells Amitabha Mazumder, Timothy J. Eberlein, Elizabeth A. Grimm, Cancer	1984	116
Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma Steven K. Jacobs, Debra J. Wilson, Paul L. Kornblith, Journal of neurosurgery	1986	91
In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes Steven K. Jacobs, Debra J. Wilson, Paul L. Kornblith, Journal of neurosurgery Cell TherapyApoptosisImmunologyBlood CellCell Death	1986	77
The human lymphokine-activated killer cell system Elizabeth A. Grimm, Debra J. Wilson Cellular Immunology ImmunologyImmunologic MechanismAutoimmunityImmune SystemImmunotherapy	1985	71
Interleukin-2 and lymphokine activated killer (LAK) cells in the treatment of malignant glioma: clinical and experimental studies Steven K. Jacobs, Debra J. Wilson, Gilbert Melin, Neurological Research Lak CellsApoptosisImmunologyCell DeathKiller Cells	1986	37
THE DIFFERENTIAL INHIBITORY EFFECTS EXERTED BY CYCLOSPORINE AND HYDROCORTISONE ON THE ACTIVATION OF HUMAN CYTOTOXIC LYMPHOCYTES BY RECOMBINANT INTERLEUKIN-2 VERSUS ALLOSPECIFIC CTL Elizabeth A. Grimm, Linda Muul, Debra J. Wilson Transplantation ImmunologyImmunoeditingCell DeathHr Chromium ReleasePharmacotherapy	1985	31
The human mixed lymphocyte-tumor cell interaction test Elizabeth A. Grimm, B. M. Vose, E. W. Chu, Cancer Immunology Immunotherapy Lymphoid NeoplasiaMedicineImmunologyImmunophenotypingImmunotherapy	1984	23

Page 1